TYGACIL
Brand:
TYGACIL
Manufacturer:
PFIZER
Manufacturer Details
PFIZER
Compositions:
Tigecycline 50mg infusion,
|
Strength
|
Rate
|
Packing Style
|
|
50mg inf
|
31.42
|
1 vial infusion
|
List of Related Indications:
- Intra-abdominal infection
- Skin & soft tissue infection
List Of Drugs:
- Tigecycline- Anti-infectives- (July 2006)
Indication Type Description:
Drug Interaction:
Warfarin oral anticoagulants OCs , Amphotericin chlorpromazine, Methylprednisolone , voriconazole
Indication:
LIST OF DRUGS DURING 2006
Sr.No- 114
Name of the Drug- Tigecycline powder For inj.50mg/vial Pharmacological Classification- For skin and structure infections &
intraabdominal infection
Date of Approval- 28-08-2006
Approved by U.S.FDA on 30-12-2006 (Ref- FDA approved List)
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Tigecycline Powder for injection 28-08-2006
50mg vial
For Skin & Skin Structure Infection & Abdominal Infection
Complicated intra-abdominal infections. Skin and soft tissue infections
Adverse Reaction:
GI upset, Headache, Transcient reduction in plasma creatinine levels
Contra-Indications:
Pregnancy Lactation Special precautions- Severe hepatic impairment, cholestatisis hypersensitivity to tetracyclines Intestinal perforation Sepsis/ shock Avoid sun, UV light Hospital acquired pneumonia Labour and delivery
Dosages/ Overdosage Etc:
Indication-
For Skin & Skin Structure Infection & Abdominal Infection
Complicated intra-abdominal infections. Skin and soft tissue infections
Dosage-
Intiatilly 10mg by i.v. infusion over 30-60 minutes , then every 12 hours for 5-14 days
Pregnancy and lactation:
Contraindicated for use during pregnancy and lactation Observe caution, if required to be administered
